Results 91 to 100 of about 50,293 (216)

Metabolic syndrome and the risk of calcium stones [PDF]

open access: yes, 2017
Sakhaee et al in this issue have investigated whether the risk of the common calcium nephrolithiasis is associated with the metabolic syndrome (MS).
Adams-Huet, Beverley   +6 more
core  

Risk factors evaluation for urolithiasis among children [PDF]

open access: yes, 1978
BackgroundThe prevalence of pediatric urolithiasis varies from 0.01–0.03%. Urolithiasis may be caused by anatomical, metabolic and environmental factors.
Velásquez-Forero, Francisco   +5 more
core   +2 more sources

The Efficacy and Safety of Physical Therapy Techniques on Stone‐Free Rates Post‐Conventional Renal Stone Surgery

open access: yesTrends in Urology &Men's Health, Volume 17, Issue 1, February 2026.
ABSTRACT Persisting small renal stone fragments remain a challenge after conventional renal stone treatment (ESWL or endoscopic treatment). Physical vibration therapy and patient inversion therapy are new techniques developed with the aim of increasing the stone‐free rate (SFR).
Yam Ting Ho   +4 more
wiley   +1 more source

Современные представления о эпидемиологии и патогенезе уролитиаза [PDF]

open access: yes, 2016
Проведен литературный обзор научных трудов за последние 20 лет, используя ресурсы поисковых систем PubMed и eLIBRARY.
Батищев, С. А.   +4 more
core   +2 more sources

Efficacy and safety of glucagon‐like peptide 1 receptor agonists across all health outcomes in type 2 diabetes: An umbrella review and evidence map of randomised controlled trials

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1136-1149, February 2026.
Abstract Aim Glucagon‐like peptide 1 receptor agonists (GLP‐1RAs) have been established as effective treatments for type 2 diabetes, offering benefits beyond glycaemic control; however, their associations across multiple health outcomes remain insufficiently assessed.
Dongjin Yeo   +8 more
wiley   +1 more source

Nephrolithiasis induced end stage renal disease in patients on hemodialysis in Baghdad (A Multicenter study) [PDF]

open access: yesAl Ameen Journal of Medical Sciences, 2016
Background: Kidney stones are the third most common disease of the urinary system. Nephrolithiasis still remains underappreciated cause of end stage renal disease.
Ali J. Hashim Al Saedi   +2 more
doaj  

The effect of negative, single and multi‐organism positive cultures on outcomes following PCNL

open access: yesBJUI Compass, Volume 7, Issue 1, January 2026.
Abstract Objective This study aims to explore risk factors related to positive single and multi‐organism stone cultures and their association with postoperative complications in patients undergoing percutaneous nephrolithotomy (PCNL). Subjects/Patients and Methods A retrospective review was performed on 293 PCNL patients with stone cultures at a single
Katya Hanessian   +8 more
wiley   +1 more source

Preventive treatment of nephrolithiasis with alkali citrate—a critical review [PDF]

open access: yes, 2018
Using the keywords "urolithiasis and citrate treatment”, "nephrolithaisis and citrate treatment”, "kidney stones and citrate treatment”, a Medline search revealed 635 articles published between 1 January 1966 and 1 December 2004. For the present analysis,
Hess, B., Mattle, D.
core  

Noncrystalline uric acid inhibits proteoglycan and glycosaminoglycan synthesis in distal tubular epithelial cells (MDCK) [PDF]

open access: yes, 2010
Hyperuricemia is associated with renal stones, not only consisting of uric acid (UrAc) but also of calcium oxalate (CaOx). Glycosaminoglycans (GAGs) are well-known inhibitors of growth and aggregation of CaOx crystals.
Borges, Fernanda Teixeira   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy